Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 3Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Overweight 1Metabolic Syndrome 1Insulin Resistance 1Infertility 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × drospirenone × Clear all
NCT01519401 2020-07-24

Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

Catholic University of the Sacred Heart

Phase NA Completed
50 enrolled

Polycystic Ovary Syndrome

NCT00442689 2014-06-06

Metabolic Syndrome in PCOS: Precursors and Interventions

Northwestern University

Phase NA Completed
97 enrolled 13 charts

Infertility, Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡